搜索临床试验以:1018 ISS 免疫刺激寡核苷酸
总计21个结果
-
Dynavax Technologies Corporation完全的
-
Dynavax Technologies CorporationPPD; Synteract, Inc.完全的
-
Ronald LevyBristol-Myers Squibb完全的
-
Robert LowskyNational Cancer Institute (NCI); Janssen, LP; The Leukemia and Lymphoma Society; Rising Tide Foundation完全的套细胞淋巴瘤 | 边缘区淋巴瘤 | 复发性滤泡性淋巴瘤 | 难治性滤泡性淋巴瘤 | 1 级滤泡性淋巴瘤 | 2 级滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤美国
-
Ronald LevyNational Cancer Institute (NCI)主动,不招人套细胞淋巴瘤 | 边缘区淋巴瘤 | 淋巴浆细胞性淋巴瘤 | B细胞非霍奇金淋巴瘤 | 小淋巴细胞淋巴瘤 | 1 级滤泡性淋巴瘤 | 2 级滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤美国
-
Robert LowskyNational Cancer Institute (NCI)完全的粘膜相关淋巴组织结外边缘区B细胞淋巴瘤 | 淋巴结边缘区 B 细胞淋巴瘤 | 复发性 1 级滤泡性淋巴瘤 | 复发性 2 级滤泡性淋巴瘤 | 复发性边缘区淋巴瘤 | 脾边缘区淋巴瘤 | 复发性小淋巴细胞淋巴瘤美国
-
Brigham and Women's HospitalGlaxoSmithKline; Ionis Pharmaceuticals, Inc.撤销
-
University of California, DavisBristol-Myers Squibb; National Cancer Institute (NCI); Dynavax Technologies Corporation完全的
-
Dynavax Technologies CorporationUnited States Department of Defense完全的
-
Clover Biopharmaceuticals AUS Pty Ltd终止
-
Clover Biopharmaceuticals AUS Pty LtdInternational Vaccine Institute; Coalition for Epidemic Preparedness Innovations完全的新冠肺炎哥伦比亚, 比利时, 巴西, 菲律宾, 南非
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; University of Rochester; Dynavax Technologies... 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...Fred Hutchinson Cancer Center; International AIDS Vaccine Initiative; HIV Vaccine Trials Network; Dynavax Technologies Corporation 和其他合作者主动,不招人
-
Sun Pharmaceutical Industries Limited撤销
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; ISA Pharmaceuticals B.V.完全的